Viewing Study NCT00545831



Ignite Creation Date: 2024-05-05 @ 6:48 PM
Last Modification Date: 2024-10-26 @ 9:37 AM
Study NCT ID: NCT00545831
Status: TERMINATED
Last Update Posted: 2013-03-05
First Post: 2007-10-16

Brief Title: Effect of Taurolidin on Prevention of Bloodstream Infection
Sponsor: University Hospital Rouen
Organization: University Hospital Rouen

Study Overview

Official Title: Prevention of Central Veinous Device Related Sepsis Relapse With Taurolidine in Patients on Parenteral Nutrition in Long-term Home
Status: TERMINATED
Status Verified Date: 2013-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: lack of recruitment
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: Nutrilock
Brief Summary: Home parenteral nutrition HPN is a validated technique for patients with various intestinal disease leading to chronic malabsorption or obstruction whatever the aetiology Intravascular catheter-related bloodstream infections CRBSI is the more frequent complication of patients with HPN and an important cause of morbidity and mortality in these patients Moreover CRBSI often recur after a first treatment of the catheter with a combination of an antibiotic lock on the catheter and systemic intravenous antibiotics In more than 50 of the cases another CRBSI will occur in a median delay of 5 months

The aim of the study is to evaluate the efficacy of a taurolidine lock secondary prophylaxis on CRBSI recurrence in HPN patients

Study population is separated in 2 groups the first one receiving the Taurolock and the second one receiving a placebo This is a randomized double-blind six-month study
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
2007-A00618-45 None None None